Amkay Products
Amkay Products
HealthcareKey Fundamentals
SMEMedical EquipmentHealthcareTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 0.68% over past five years.
- Company has a low return on equity of 13.2% over last 3 years.
Growth Rate
Quarterly Results
| Particulars | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 14.37 | 16.69 | 17.84 | 20.55 | 23.01 | 19.02 |
| Expenses | 12.58 | 15.15 | 15.45 | 18.81 | 20.04 | 18.15 |
| Operating Profit | 1.79 | 1.54 | 2.39 | 1.74 | 2.97 | 0.87 |
| OPM % | 12.46% | 9.23% | 13.4% | 8.47% | 12.91% | 4.57% |
| Other Income | 0.48 | 0.76 | 0.73 | 0.59 | 0.39 | 0.28 |
| Interest | 0.24 | 0.28 | 0.18 | 0.14 | 0.25 | 0.18 |
| Depreciation | 0.26 | 0.3 | 0.34 | 0.49 | 0.43 | 0.46 |
| PBT | 1.77 | 1.72 | 2.6 | 1.7 | 2.68 | 0.51 |
| Tax % | 26.55% | 23.26% | 30% | 10.59% | 26.87% | 33.33% |
| Net Profit | 1.3 | 1.33 | 1.83 | 1.51 | 1.97 | 0.34 |
| EPS in Rs | 2.04 | 2.09 | 2.11 | 1.74 | 2.28 | 0.39 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 26.41 | 40.63 | 36.47 | 27.86 | 31.07 | 38.39 | 42.03 |
| Expenses | 24.82 | 36.14 | 33.78 | 24.93 | 27.74 | 34.26 | 38.18 |
| Operating Profit | 1.59 | 4.49 | 2.69 | 2.93 | 3.33 | 4.13 | 3.85 |
| OPM % | 6.02% | 11.05% | 7.38% | 10.52% | 10.72% | 10.76% | 9.16% |
| Other Income | 0.04 | 0.1 | 0.29 | 0.46 | 1.25 | 1.32 | 0.67 |
| Interest | 0.47 | 0.24 | 0.41 | 0.47 | 0.52 | 0.32 | 0.43 |
| Depreciation | 0.52 | 0.51 | 0.54 | 0.69 | 0.56 | 0.83 | 0.88 |
| PBT | 0.64 | 3.84 | 2.03 | 2.23 | 3.5 | 4.3 | 3.21 |
| Tax % | 25% | 25% | 28.08% | 30.49% | 24.86% | 22.33% | 27.73% |
| Net Profit | 0.48 | 2.88 | 1.47 | 1.55 | 2.63 | 3.34 | 2.31 |
| EPS in Rs | 173 | 1,040 | 531 | 560 | 4.13 | 3.86 | 2.67 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.28 | 0.28 | 0.28 | 0.28 | 6.36 | 8.66 | 8.66 |
| Reserves | 2.42 | 5.67 | 5.93 | 7.1 | 3.64 | 15.41 | 17.72 |
| Borrowings | 1.62 | 0.42 | 4.33 | 4.7 | 5.47 | 2.64 | 3.93 |
| Other Liabilities | 2.55 | 7.69 | 5.26 | 2.9 | 2.47 | 3.18 | 3 |
| Total Liabilities | 6.87 | 14.06 | 15.8 | 14.98 | 17.94 | 29.89 | 33.31 |
| Fixed Assets | 0 | 0 | 3.91 | 2.4 | 2.58 | 4.14 | 4.27 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0.12 | 0 |
| Investments | 0 | 0.4 | 2.79 | 3.62 | 2.57 | 6.85 | 6.5 |
| Other Assets | 6.87 | 13.66 | 9.1 | 8.96 | 12.79 | 18.78 | 22.54 |
| Total Assets | 6.87 | 14.06 | 15.8 | 14.98 | 17.94 | 29.89 | 33.31 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 0 | 0 | -0.25 | 0.01 | -0.66 | -0.32 | 1.18 |
| Investing | 0 | 0 | -3.07 | -0.34 | 0.48 | -5.84 | -0.4 |
| Financing | 0 | 0 | 2.59 | 0.31 | 0.24 | 7.59 | 0.86 |
| Net Cash Flow | 0 | 0 | -0.72 | -0.01 | 0.06 | 1.43 | 1.64 |
| Free Cash Flow | 0 | 0 | -2.4 | -0.01 | -1.82 | -3.05 | 0.28 |
| CFO/OP | 0 | 0 | 10 | 32 | 7 | 17 | 54 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31.23 | 40.43 | 36.33 | 48.47 | 46.87 | 57.14 | 42.81 |
| Inventory Days | 4.54 | 4.18 | 28.03 | 46.61 | 92.57 | 113 | 125 |
| Days Payable | 41.76 | 82.57 | 64.42 | 44.46 | 33.99 | 36.44 | 28.98 |
| Cash Conversion Cycle | -5.98 | -37.96 | -0.06 | 50.62 | 105 | 134 | 139 |
| Working Capital Days | 10.78 | -8.62 | 21.12 | 54.11 | 56.15 | 104 | 96.4 |
| ROCE % | — | 76.33% | 28.86% | 20.87% | 22.36% | 16.88% | 12.77% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Amkay Products insights
54 extracted metrics + investor summaries across FY20–FY26.
Documents
Frequently Asked Questions about Amkay Products
What does Amkay Products Ltd do?
Where is Amkay Products Ltd (544169) listed?
Which sector does Amkay Products Ltd belong to?
What is the market capitalisation of Amkay Products Ltd?
What is the PE ratio of Amkay Products Ltd?
What is the 52-week high and low of Amkay Products Ltd?
What is the Return on Equity (ROE) of Amkay Products Ltd?
Company Information
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544169.md for Amkay Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.